3V4A
Structure of ar lbd with activator peptide and sarm inhibitor 2
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE BM30A |
Synchrotron site | ESRF |
Beamline | BM30A |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2007-12-12 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.934 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 54.446, 66.805, 69.854 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 10.000 - 1.950 |
R-factor | 0.1718 |
Rwork | 0.172 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 2ama |
RMSD bond length | 0.007 |
RMSD bond angle | 0.023 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | SHELX |
Refinement software | SHELXL-97 |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 36.100 | 2.100 |
High resolution limit [Å] | 1.950 | 1.950 |
Rmerge | 0.051 | 0.193 |
Number of reflections | 18995 | |
<I/σ(I)> | 35.5 | 5.4 |
Completeness [%] | 99.5 | 97.8 |
Redundancy | 4.4 | 3.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 7.5 | 291 | Hanging drop set up as a 50:50 mixture of 1 uL protein, 1 uL reservoir with: A) protein solution = 80 uL hAR LBD (3.5 mg/ml), 1.5 uL undecapeptide, 1 uL LiSO4 (0.2 M) in HEPES buffer 0.1 M, 0.5 mg inhibitor 2 (PK1) Reservoir 1 ml HEPES buffer 0.1 M, PEG 4000 12-20 %, pH 7.5, VAPOR DIFFUSION, temperature 291K |